Arthur Kavanaugh, MD

UCSD
La Jolla, CA, United States

Professor of Medicine, UCSD. Director, Center for Innovative Therapy, UCSD Division of Rheumatology, Allergy, Immunology

Disclosure information not submitted.

Presentation(s):

• 1038: Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Ankylosing Spondylitis

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 2109: Domains Contributing to Minimal Disease Activity Non-Achievement in Patients with Psoriatic Arthritis Receiving Golimumab: Post Hoc Analysis of a Phase 3, Randomized, Double-blind, Placebo-controlled Study

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time

• 2136: Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in a Phase 2 Trial in Psoriatic Arthritis: Achievement of Minimal Disease Activity and Its Components

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time